Presentations from meetings

class=”alignright wp-image-4283″ src=”http://www.ukcab.net/wp-content/uploads/2016/01/UK-CAB-logo-colour-1.jpeg” alt=”” width=”140″ height=”206″ />Reports, briefings and presentations from UK-CAB meetings.

This includes PowerPoint slide and PDFs.

It also includes links to selected additional materials on other websites.

All material has been presented or discussed at UK-CAB meetings.

 

U=U discussion feedback

TasP for sexual reproduction health

BHIVA 2018 pregnancy guidelines feedback

BHIVA BASHH clinical feedback 2 of 2

BHIVA BASHH clinical feedback 1 of 2

Mind the gap – transition to adult care

HIV medicine and a bit of basic science

Health and wellbeing outcomes in PLWH with and without depression

Increased physical activity amongst HIV positive individuals

National standards of HIV peer support

The changing landscape of cervical screening – What does the future hold for HIV positive women?

BHIVA spring conference 2017 feedback

Use of generic medication: a commissioning perspective

Generic HIV drugs

CROI 2017 feedback

MSD pre-meeting

Getting the most out of your general practitioner

Shared care: Findings from the BHIVA primary care project

BHIVA SHR guidelines on assisted conception

BHIVA Audit and Standards subcommittee feedback

Living with TB and HIV – a personal experience

TB services across England

HIV and lung health

Additional files:

IAS and R4P conferences feedback

BHIVA autumn feedback

HIV Glasgow conference feedback

BME access to mental health in Leicester

HIV neurology

Cognitive impairment in well treated cohorts – 1 of 2

Cognitive impairment in well treated cohorts – 2 of 2

SELPHI study

The menopause in women living with HIV

PrEP update – NAT

Ageing with HIV conference feedback

Linkage to care following HIV diagnosis

Stigma index 2015 survey

Living with HIV and diabetes: the perfect storm

Type 2 Diabetes in HIV

Insulin resistance and diabetes mellitus in HIV infection

Effects of ART on the kidney: Which ones matter? – Falcon trial

HIV respiratory disease study

HIV cure research update

Community perspective on HIV cure

Community feedback: START study

Hepatitis C genotypes

DAAs for HCV infection – are we there yet?

ChemSex and HIV HCV co-infection

Additional files:

BHIVA feedback

CPAG Prioritisation Framework

CROI 2015 feedback

BHIVA Treatment Guidelines consultation 2015

TasP and PrEP – a policy perspective

TasP and PrEP – doctor’s perspective

PROUD study update

Patient perspective on PrEP

HIV and sexual happiness

HIV and erectile dysfunction

Chemsex – sexualised drug use by MSM

Who accesses PrEP? PROUD study baseline data analysis

In Treatment: improving psychological wellbeing in the HIV clinic

Setting the standards in providing HIV psychological support – engaging service users

Patient experience on mental health and HIV

NIHR study to assess low dose efavirenz

States of Mind: Improving mental health in the HIV community

Introduction to why there is a UK-CAB

Introduction to clinical trials

AllTrials.org campaign

The changing landscape of biomedical HIV prevention research

BHIVA Spring Conference 2014

The International Liver Congress

NHS England: Patients at the heart of the agenda

Healthwatch England – a platform for action

Local government and Health and Wellbeing Boards

Introduction to Hepatitis C

HCV monitoring, treatment and studies update

HCV self-management training

POPPY study update

EACS Conference feedback

The HIV journey from paediatric to adult services

Epidemiology of perinatal HIV in the UK/Ireland

Growing up with HIV – the paediatric legacy for adult services – part 1/2

Growing up with HIV – the paediatric legacy for adult services – part 2/2

HIV and cancer – part 1 of 3

Additional files:

Introduction to HIV and cancer

Introduction to HIV cure research: pieces in the puzzle

Current research towards an HIV cure

Drug development process, an introduction

Drug development in relation to PrEP and PROUD studies

Access campaign – MSF

Make women count

Washington Snapshot

WAC feedback: Living2012, 2015 pledge

Access campaign – MSF

AIDS2012 – History and hepatitis

IAS feedback

Bone health and exercise

Bone health and Vitamin D deficiency in HIV+ patients

Body and Soul – BHIVA community poster research

UK CHIC

Estimating loss to follow up among persons accessing HIV care in England, Wales and Northern Ireland

HIV Drug Resistance

Less frequent tests, what impact on HIV care?

Patient reporting of medicines-related problems

HIV Activism at 30

Patient information security

Company meeting with Janssen

Strengething community response to TB-HIV

TB and HIV treatment and screening

The XX Factor – women and HIV

HIV research and gender

Gender and HIV research: history and overview

HIV and brain function

HIV, antiretroviral therapy and the brain

London drug commissioning 2011

iPrEX Trial Design: statistical aspect of the results relating to the adherence data

Genital Tract ART Implications for transmission 2010

CROI 2010 feedback

Poster: Africans in UK present late and are likely to be on ARVs soon after an HIV diagnosis

HIV and MSM in England: A new wave of challenge

African sub-groups session Issues for Men

African Treatment Issues and HPA data on late diagnosis

Feedback from BHIVA Conference

Ageing with HIV: Project overview Frontline HIV Forum

Proposed Ageing Study

IAS Feedback Cape Town 2009

BMS Data Update

Additional files:

Advocacy Training in Practice

Additional files:

HIV Treatment Advocacy Overview

Additional files:

Draft BHIVA Guidelines Routine Monitoring of HIV

Additional files:

BHIVA feedback

Additional files:

Feedback from CROI – BHIVA

HIV and Drug Resistance

Introducing the HIV Vaccine Advisory Board

Additional files:

When to Start Therapy? The Patient’s Viewpoint

A rough guide to the immune system

Intelence (Etravirine) Update

TMC278 Update

TMC207 Update

Etravirine, Darunavir and pipeline HIV plus HCV and TB

Overview

Mexico feedback: research overview

Mexico feedback: social issues

Additional files:

BHIVA/CHIVA feedback

Matt Williams, UK-CAB, 2008  [PowerPoint, 369 Kb]

Additional files:

Young people and HIV: a social support perspective

Maria Phelan, NCB, Oct 2008  [PDF, 256 Kb]

Additional files:

Undetectable = uninfectious? Treatment as prevention

Dr Bernard Hirschel, University Hospital, Geneva, 2008  [PDF, 232 Kb]

Undetectable = uninfectious? Community response

Edwin J Bernard, NAM, 2008  [PowerPoint, 375 Kb]

Undetectable = uninfectious? Community response

Silvia Petretti, Positively Women/PozFem UK, 2008  [PowerPoint, 245 Kb]

Guidance for public on reporting side effects

Guidance for public on reporting side effects

(link to external site) MRHA, 2008  [PDF, 65 Kb]

10 essential actions for effective TB infection control

10 essential actions for effective TB infection control

(link to external site) Stop TB Partnership, 2008  [PDF, 231 Kb]

Describing the risk of an event and identifying risk factors

Dr Caroline Sabin, Royal Free Hospital, 2008  [PowerPoint, 336 Kb]

CROI 2008 feedback: understanding statistics in 3 studies

Simon Collins, HIV i-Base, 2008  [PDF, 4 Mb]

D:A:D position statement – abacavir, ddI and risk of heart attack

D:A:D position statement

(link to external site) D:A:D steering committee, 2008  [PDF, 63 Kb]

Immigration removal centres and HIV

Joe Murry, Policy Officer, NAT, 2007  [PowerPoint, 214 Kb]

Tests and monitoring in HIV infection

Matt Williams, UK CAB, 2007  [PowerPoint, 558 Kb]

Viral tropism

Matt Williams, UK CAB, 2007  [PDF, 592 Kb]

Monitoring HIV infection and treatment in the era of HAART

Dr Simon Edwards, Mortimer Market Centre, 2007  [PowerPoint, 152 Kb]

Sisters are doing it for themselves: women, sexual health and HIV

(link to external site) HIV Scotland, 2007  [PDF, 1.5 Mb]

BHIVA Audit 2006-7: survey of patient assessment and monitoring

BHIVA Audit 2006-7: survey of patient assessment and monitoring

(link to external site) BHIVA, 2007  [PDF, 80 Kb]

Women, HIV and microbicides seminar report

Women, HIV and microbicides seminar report

(link to external site) George House Trust and UK African Microbicides Working Group, 2007  [PDF, 210 Kb]

BHIVA standards project

Hilary Curtis, 2006  [PowerPoint, 258 Kb]

Human rights protection for people with HIV/AIDS

Human rights protection for people with HIV/AIDS

(link to external site) Hermione McEwen, Senior Solicitor, Greater Manchester Immigration Aid Unit, 2006  [PowerPoint, 42 Kb]

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

(link to external site) Department of Health, 2008  [PDF, 493 Kb]

Update on the neurological manifestations of HIV

Justin McArthur, MBBS, MPH, Professor of Neurology and Epidemiology, Johns Hopkins University School of Medicine (PRN Notebook), 2005  [PDF, 192 Kb]

CAB steering group feedback

Mark McPherson, UK CAB, 2005  [PowerPoint, 164 Kb]

HIV Clinical trials at MRC Clinical Trials Unit

Nick Paton, MRC Clinical Trials Unit, 2005  [PowerPoint, 1.3 Mb]

Entry inhibitors and immunology

Simon Collins, HIV i-Base, 2005  [PowerPoint, 116 Kb]

Paediatric HIV care

HIV i-Base, 2005  [PowerPoint, 547 Kb]

BHIVA treatment guidelines 2005

Simon Collins, HIV i-Base, 2005  [PowerPoint, 84 Kb]

BHIVA guidelines: what’s new – new drugs

Brian West, HIV Scotland, 2005  [PDF, 620 Kb]

Participating in an HIV vaccine trial

Jo Robinson, EATG Vaccines Working Group, 2004  [PowerPoint, 212 Kb]

HIV vaccine clinical trials: the need for community involvement

Ken Legg, Imperial College of London, 2004  [PowerPoint, 448 Kb]

Community participation in western Europe

Emmanuel Trénado, EATG Vaccines Working Group, 2004  [PowerPoint, 2.1 Mb]

Community participation in eastern Europe

Dmitry Samoylov, Community of People Living with HIV/AIDS, Moscow, 2004  [PDF, 1.4 Mb]

European AIDS vaccine trials: an advocacy agenda

Marion Zibelli, EATG Vaccine Working Group, 2004  [PowerPoint, 148 Kb]

Statistics part 3: design of randomised controlled trials of treatments for HIV infection

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2004  [PowerPoint, 312 Kb]

Introduction to basic vaccine technology

Henry Graeme-Smith, 2004  [PowerPoint, 416 Kb]

Topical microbicides

Jo Robinson, THT in cooperation with the Global Campaign for Microbicides, 2004  [PowerPoint, 3.4 Mb]

International AIDS Vaccine Initiative

Maite Suarez, IAVA, 2004  [PowerPoint, 1.9 Mb]

Community involvement in vaccine and microbicide research

Julian Meldrum, 2004  [PowerPoint, 48 Kb]

Thorny issues in HIV vaccine trials

Saul Walker, Policy Advisor. IAVI, 2004  [PowerPoint, 272 Kb]

Towards error-free HIV diagnosis: guidelines on laboratory practice

Towards error-free HIV diagnosis: guidelines on laboratory practice

(link to external site) JV Parry, PP Mortimer, KR Perry, D Pillay, M Zuckerman, for the Health Protection Agency HIV Laboratory Diagnosis Message board (Communicable Disease and Public Health), December 2003  [PDF, 332 Kb]

Statistics part 2: hypothesis (significance) testing – more complex statistical methods

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003  [PDF, 464 Kb]

Statistics part 1: different types of study design – describing and displaying data

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003  [PDF, 628 Kb]

Enfuvirtide (T-20)

Roche, Leroy Benons, Medical Advisor – HIV, Roche, 2003  [PowerPoint, 5 Mb]

Access to HIV treatment: issues of working with HIV positive refugees and asylum seekers

Linda McDonald MA MSc RN, 2003  [PowerPoint, 61 Kb]

TB and HIV

Dr Anton Pozniak, Chelsea and Westminster Hospital, 2003  [PowerPoint, 880 Kb]

Hepatits C/HIV coinfection

Dr Ranjababu Kulasegaram, Guy’s and St Thomas’ Hospital, 2003  [PDF, 748 Kb]

Additional files:

Principles of care of the HIV-1 infected pregnant mother

Principles of care of the HIV-1 infected pregnant mother

(link to external site) Dr Karen Beckerman, Assistant Professor of Obstetrics and Gynaecology, New York University, October 2002  [PDF, 5.1 Mb]

HIV and subfertility

Leila Frodsham, Clinical Research Fellow, Assisted Conception Unit, Chelsea and Westminster, 2002  [PowerPoint, 338 Kb]

Tipranavir: design of the RESIST study

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 468 Kb]

Unique resistance profile of tipranavir

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 696 Kb]

Clinical aspects of treatment with tipranavir

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 444 Kb]

Understanding HIV-1 drug resistance testing

Professor Clive Loveday, International Clinical Virology Centre, 2002  [PDF, 2.5 Mb]

Salvage therapy

Dr Mike Youle, Royal Free Centre for HIV Medicine, 2002  [PDF, 1.1 Mb]

Methods of drug evaluation

Tim Peto, MRC Clinical Trials Unit, 2002  [PowerPoint, 332 Kb]

Additional files:

Gilead: tenofovir

Gilead Sciences, 2002  [PDF, 328 Kb]

Additional files:

Atazanavir

BMS, 2002  [PowerPoint, 834 Kb]

Informed consent and patient involvement in trials

Norbert Tamm, Research Charge Nurse, Imperial College and St Mary’s Hospital, 2002  [PowerPoint, 52 Kb]

Additional files:

d4T (stavudine, Zerit) extended release

BMS, 2002  [PowerPoint, 166 Kb]

DPC 083-201 (DuPont 083)

Dr Nancy Ruiz, 2002  [PowerPoint, 914 Kb]

What are observational studies?